Candidate cancer-targeting agents identified by expression-profiling arrays
作者： Apiwat Mutirangura , Vittavat Termglinchan , Wanichnopparat , Suwanwongse , Teeyapant
DOI: 10.2147/OTT.S42858
关键词:
摘要: Background One particularly promising component of personalized medicine in cancer treatment is targeted therapy, which aims to maximize therapeutic efficacy while minimizing toxicity. However, the number approved agents remains limited. Expression microarray data for different types are resources identify genes that were upregulated. The candidate targets cancer-targeting future anticancer research and treatments.
researchgate.net 
sci-hub.se 参考文章(57)
Antonella Sassano, Leonidas C. Platanias, Statins in tumor suppression. Cancer Letters. ,vol. 260, pp. 11- 19 ,(2008) , 10.1016/J.CANLET.2007.11.036
Clifford A. Hudis, Trastuzumab — Mechanism of Action and Use in Clinical Practice The New England Journal of Medicine. ,vol. 357, pp. 39- 51 ,(2007) , 10.1056/NEJMRA043186
Nadir Arber, Craig J. Eagle, Julius Spicak, István Rácz, Petr Dite, Jan Hajer, Miroslav Zavoral, Maria J. Lechuga, Paola Gerletti, Jie Tang, Rebecca B. Rosenstein, Katie Macdonald, Pritha Bhadra, Robert Fowler, Janet Wittes, Ann G. Zauber, Scott D. Solomon, Bernard Levin, Celecoxib for the Prevention of Colorectal Adenomatous Polyps The New England Journal of Medicine. ,vol. 355, pp. 885- 895 ,(2006) , 10.1056/NEJMOA061652
John A Baron, Robert S Sandler, Robert S Bresalier, Hui Quan, Robert Riddell, Angel Lanas, James A Bolognese, Bettina Oxenius, Kevin Horgan, Susan Loftus, Dion G Morton, APPROVe Trial Investigators, A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas Gastroenterology. ,vol. 131, pp. 1674- 1682 ,(2006) , 10.1053/J.GASTRO.2006.08.079
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart, Patrick Tarpey, Ignacio Varela, Benjamin Phillimore, Sharmin Begum, Neil Q McDonald, Adam Butler, David Jones, Keiran Raine, Calli Latimer, Claudio R Santos, Mahrokh Nohadani, Aron C Eklund, Bradley Spencer-Dene, Graham Clark, Lisa Pickering, Gordon Stamp, Martin Gore, Zoltan Szallasi, Julian Downward, P Andrew Futreal, Charles Swanton, None, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. The New England Journal of Medicine. ,vol. 366, pp. 883- 892 ,(2012) , 10.1056/NEJMOA1113205
Sune F. Nielsen, Børge G. Nordestgaard, Stig E. Bojesen, Statin Use and Reduced Cancer-Related Mortality The New England Journal of Medicine. ,vol. 367, pp. 1792- 1802 ,(2012) , 10.1056/NEJMOA1201735
Marcus Gry, Rebecca Rimini, Sara Strömberg, Anna Asplund, Fredrik Pontén, Mathias Uhlén, Peter Nilsson, Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics. ,vol. 10, pp. 365- 365 ,(2009) , 10.1186/1471-2164-10-365
Joseph A DiMasi, Ronald W Hansen, Henry G Grabowski, Louis Lasagna, Cost of innovation in the pharmaceutical industry. Journal of Health Economics. ,vol. 10, pp. 107- 142 ,(1991) , 10.1016/0167-6296(91)90001-4
Marek Jakobisiak, Jakub Golab, Statins can modulate effectiveness of antitumor therapeutic modalities. Medicinal Research Reviews. ,vol. 30, pp. 102- 135 ,(2010) , 10.1002/MED.20162
Daniela S. Krause, Richard A. Van Etten, Tyrosine kinases as targets for cancer therapy. The New England Journal of Medicine. ,vol. 353, pp. 172- 187 ,(2005) , 10.1056/NEJMRA044389